S100A4-neutralizing antibody suppresses spontaneous tumor progression, pre-metastatic niche formation and alters T-cell polarization balance

Overview of attention for article published in BMC Cancer, February 2015

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

twitter: 1 X user

patent: 2 patents

Citations

dimensions_citation: 51 Dimensions

Readers on

mendeley: 49 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

ANTI-S100A4 HUMANIZED ANTIBODIES, USES AND METHODS

Application WO-2022171656-A1

World Intellectual Property Organisation (WIPO)

ANTI-S100A4 ANTIBODIES FOR THE TREATMENT OF SYSTEMIC SCLEROSIS

Application WO-2022003042-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.